Related Experiment Videos
Development of radioimmunoassays for drugs
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (AS1404), a novel vascular disrupting agent, in phase I clinical trial.
Cancer chemotherapy and pharmacology·2006
Species differences in the metabolism of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in vitro: implications for prediction of metabolic interactions in vivo.
Xenobiotica; the fate of foreign compounds in biological systems·2002
Identification and reactivity of the major metabolite (beta-1-glucuronide) of the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humans.
Xenobiotica; the fate of foreign compounds in biological systems·2001
Effects of anticancer drugs on the metabolism of the anticancer drug 5,6-dimethylxanthenone-4-acetic (DMXAA) by human liver microsomes.
British journal of clinical pharmacology·2001
[Treatment algorithm for gastrointestinal graft-versus-host disease].
Methods and findings in experimental and clinical pharmacology·2011
[Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].
Methods and findings in experimental and clinical pharmacology·2011
[Classification of chronic graft-versus-host disease].
Methods and findings in experimental and clinical pharmacology·2011
[Pegfilgrastim in hematopoietic stem cell transplantation].
Methods and findings in experimental and clinical pharmacology·2011
[Allogeneic transplantation in multiple myeloma patients: results and recommendations in February 2010].
Methods and findings in experimental and clinical pharmacology·2011
[Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].
Methods and findings in experimental and clinical pharmacology·2011
Nanovesicle-formulated Sterculia coccinea Jack (hantap) leaf extract: Estrogen receptor-alpha molecular docking and cytotoxicity in Michigan Cancer Foundation-7 cells.
Journal of advanced pharmaceutical technology & research·2026